Medical testing giant Quest Diagnostics (NYSE: DGX) stock slipped 5.1% through 11:30 a.m. Tuesday, after the Centers for Medicare & Medicaid Services (CMS) disclosed Monday that they've been paying about 16% more for lab work than private insurers pay. No longer. Effective Jan. 1, 2027, CMS says...